Source: BioSpace

LogicBio: LogicBio Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders - June 05, 2020

LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, announced that its 2020 Annual Meeting of Stockholders will be held in a virtual-only format due to continued public health concerns related to coronavirus / COVID-19, and to support the health and well-being of our stockholders and other meeting participants.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Frederic Chereau's photo - President & CEO of LogicBio

President & CEO

Frederic Chereau

CEO Approval Rating

82/100

LogicBio is a biotechnology company that develops genetic medicines to treat rare pediatric diseases. Read more